Bank of Montreal’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $104M | Buy |
459,768
+13,899
| +3% | +$2.48M | 0.03% | 384 |
|
|
2026
Q1 | $76.9M | Buy |
445,869
+57,952
| +15% | +$10.7M | 0.03% | 422 |
|
|
2025
Q4 | $77.4M | Buy |
387,917
+356,889
| +1,150% | +$64.7M | 0.03% | 429 |
|
|
2025
Q3 | $4.85M | Buy |
31,028
+5,911
| +24% | +$939K | ﹤0.01% | 1297 |
|
|
2025
Q2 | $3.81M | Sell |
25,117
-4,275
| -15% | -$570K | ﹤0.01% | 1357 |
|
|
2025
Q1 | $4.42M | Sell |
29,392
-13,805
| -32% | -$2.31M | ﹤0.01% | 1208 |
|
|
2024
Q4 | $7.97M | Sell |
43,197
-2,032
| -4% | -$391K | ﹤0.01% | 1056 |
|
|
2024
Q3 | $8.97M | Sell |
45,229
-1,975
| -4% | -$410K | ﹤0.01% | 1090 |
|
|
2024
Q2 | $9.95M | Buy |
47,204
+3,393
| +8% | +$769K | ﹤0.01% | 1005 |
|
|
2024
Q1 | $11.8M | Sell |
43,811
-2,265
| -5% | -$541K | ﹤0.01% | 920 |
|
|
2023
Q4 | $11M | Buy |
46,076
+10,937
| +31% | +$2.15M | ﹤0.01% | 995 |
|
|
2023
Q3 | $7.33M | Buy |
35,139
+5,405
| +18% | +$1.11M | ﹤0.01% | 1129 |
|
|
2023
Q2 | $6.32M | Buy |
29,734
+1,687
| +6% | +$336K | ﹤0.01% | 1226 |
|
|
2023
Q1 | $5.66M | Sell |
28,047
-4,898
| -15% | -$1.11M | ﹤0.01% | 1186 |
|
|
2022
Q4 | $7.36M | Buy |
32,945
+3,571
| +12% | +$780K | ﹤0.01% | 1109 |
|
|
2022
Q3 | $5.85M | Sell |
29,374
-5,567
| -16% | -$1.2M | ﹤0.01% | 1266 |
|
|
2022
Q2 | $7.83M | Buy |
34,941
+8,990
| +35% | +$2.2M | ﹤0.01% | 1173 |
|
|
2022
Q1 | $7.53M | Sell |
25,951
-9,365
| -27% | -$2.89M | ﹤0.01% | 1280 |
|
|
2021
Q4 | $13.3M | Sell |
35,316
-37,747
| -52% | -$14.7M | 0.01% | 872 |
|
|
2021
Q3 | $31M | Buy |
73,063
+26,590
| +57% | +$11M | 0.01% | 732 |
|
|
2021
Q2 | $17.3M | Buy |
46,473
+33,848
| +268% | +$11.3M | 0.01% | 976 |
|
|
2021
Q1 | $3.85M | Sell |
12,625
-678
| -5% | -$188K | ﹤0.01% | 1472 |
|
|
2020
Q4 | $3.68M | Buy |
13,303
+194
| +1% | +$46.2K | ﹤0.01% | 1545 |
|
|
2020
Q3 | $3.06M | Sell |
13,109
-15,432
| -54% | -$3.2M | ﹤0.01% | 1464 |
|
|
2020
Q2 | $5.28M | Buy |
28,541
+7,876
| +38% | +$1.26M | ﹤0.01% | 1141 |
|
|
2020
Q1 | $2.51M | Sell |
20,665
-20,082
| -49% | -$3.01M | ﹤0.01% | 1322 |
|
|
2019
Q4 | $6.22M | Buy |
40,747
+16,044
| +65% | +$2.22M | ﹤0.01% | 1229 |
|
|
2019
Q3 | $3.27M | Buy |
24,703
+200
| +0.8% | +$26.8K | ﹤0.01% | 1392 |
|
|
2019
Q2 | $3.48M | Sell |
24,503
-52,538
| -68% | -$7.13M | ﹤0.01% | 1386 |
|
|
2019
Q1 | $11.2M | Sell |
77,041
-76,742
| -50% | -$10.1M | 0.01% | 821 |
|
|
2018
Q4 | $17.4M | Sell |
153,783
-67,572
| -31% | -$8.46M | 0.02% | 599 |
|
|
2018
Q3 | $29.8M | Buy |
221,355
+210,343
| +1,910% | +$26M | 0.02% | 519 |
|
|
2018
Q2 | $1.24M | Sell |
11,012
-47,689
| -81% | -$5.16M | ﹤0.01% | 1897 |
|
|
2018
Q1 | $6.27M | Buy |
58,701
+711
| +1% | +$76.6K | 0.01% | 1054 |
|
|
2017
Q4 | $6.35M | Buy |
57,990
+4,900
| +9% | +$533K | 0.01% | 1035 |
|
|
2017
Q3 | $5.74M | Buy |
53,090
+47,063
| +781% | +$4.84M | 0.01% | 1106 |
|
|
2017
Q2 | $610K | Sell |
6,027
-209
| -3% | -$19.2K | ﹤0.01% | 2181 |
|
|
2017
Q1 | $561K | Sell |
6,236
-130
| -2% | -$11K | ﹤0.01% | 2072 |
|
|
2016
Q4 | $453K | Sell |
6,366
-33,970
| -84% | -$2.58M | ﹤0.01% | 2161 |
|
|
2016
Q3 | $3.36M | Buy |
40,336
+33,860
| +523% | +$2.84M | ﹤0.01% | 1265 |
|
|
2016
Q2 | $534K | Buy |
6,476
+13
| +0.2% | +$1.07K | ﹤0.01% | 2097 |
|
|
2016
Q1 | $491K | Buy |
6,463
+583
| +10% | +$43.2K | ﹤0.01% | 2049 |
|
|
2015
Q4 | $473K | Buy |
5,880
+2,123
| +57% | +$153K | ﹤0.01% | 2015 |
|
|
2015
Q3 | $240K | Buy |
3,757
+392
| +12% | +$28.1K | ﹤0.01% | 2174 |
|
|
2015
Q2 | $237K | Sell |
3,365
-195
| -5% | -$14.4K | ﹤0.01% | 2327 |
|
|
2015
Q1 | $282K | Buy |
3,560
+871
| +32% | +$64.3K | ﹤0.01% | 2220 |
|
|
2014
Q4 | $170K | Sell |
2,689
-1,193
| -31% | -$74.8K | ﹤0.01% | 2528 |
|
|
2014
Q3 | $232K | Sell |
3,882
-3,639
| -48% | -$208K | ﹤0.01% | 2464 |
|
|
2014
Q2 | $403K | Sell |
7,521
-928
| -11% | -$50.9K | ﹤0.01% | 2198 |
|
|
2014
Q1 | $510K | Buy |
8,449
+6,610
| +359% | +$385K | ﹤0.01% | 2036 |
|
|
2013
Q4 | $97K | Sell |
1,839
-29
| -2% | -$1.46K | ﹤0.01% | 2554 |
|
|
2013
Q3 | $87K | Buy |
1,868
+23
| +1% | +$1.05K | ﹤0.01% | 2565 |
|
|
2013
Q2 | $76K | Buy |
+1,845
| New | +$79K | ﹤0.01% | 2529 |
|
Other funds holding CRL
AI
Bank of Montreal's CRL Position: Q2 2026 in Review
Bank of Montreal increased its Charles River Laboratories (CRL) stake by 3.1% in Q2 2026, buying an estimated $2.48M and bringing the position to 459,768 shares worth $104M. The position accounts for 0.03% of the portfolio, ranked #384.
Bank of Montreal first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Bank of Montreal held 459,768 shares of Charles River Laboratories worth $104M as of Q2 2026.
- Bank of Montreal bought 13,899 Charles River Laboratories shares in Q2 2026, an estimated $2.48M.
- Charles River Laboratories made up 0.03% of Bank of Montreal's portfolio in Q2 2026, its #384 holding.
- Bank of Montreal first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.